Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8
1 clinical trials · Condition
◉ Watch Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8
| Record | Firm | Date |
|---|---|---|
| Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer (NCT04285671) | Jonsson Comprehensive Cancer Center | 2021-01-29 |
Track Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 automatically
Every clearance here is in the API, with alerts when new ones post.